1,541
Views
27
CrossRef citations to date
0
Altmetric
Original Research

Characterization of the cryoablation-induced immune response in kidney cancer patients

, , , , , , , , , & show all
Article: e1326441 | Received 10 Mar 2017, Accepted 29 Apr 2017, Published online: 28 Jun 2017

References

  • Lanza E, Palussiere J, Buy X, Grasso RF, Beomonte Zobel B, Poretti D, Pedicini V, Balzarini L, Cazzato RL. Percutaneous image-guided cryoablation of breast cancer: a systematic review. J Vasc Interv Radiol 2015; 26:1652-7 e1; PMID:26342882; https://doi.org/10.1016/j.jvir.2015.07.020
  • Rodriguez Faba O, Akdogan B, Marszalek M, Langenhuijsen JF, Brookman-May S, Stewart GD, Capitanio U, Sanguedolce F, Renal cancer working group of the Young Academic Urologists Working Party of the European Association of Urology. Current status of focal cryoablation for small renal masses. Urology 2016; 90:9-15; PMID:26743392; https://doi.org/10.1016/j.urology.2015.11.041
  • Levy D, Avallone A, Jones JS. Current state of urological cryosurgery: prostate and kidney. BJU Int 2010; 105:590-600; PMID:20149203; https://doi.org/10.1111/j.1464-410X.2010.09235.x
  • Ritch CR, Katz AE. Prostate cryotherapy: current status. Current Opinion Urol 2009; 19:177-81; PMID:19195130; https://doi.org/10.1097/MOU.0b013e32831e16ce
  • Bhardwaj N, Gravante G, Strickland AD, Ahmad F, Dormer J, Dennison AR, Lloyd DM. Cryotherapy of the liver: a histological review. Cryobiology 2010; 61:1-9; PMID:20599888; https://doi.org/10.1016/j.cryobiol.2010.06.003
  • Littrup PJ, Jallad B, Chandiwala-Mody P, D'Agostini M, Adam BA, Bouwman D. Cryotherapy for breast cancer: a feasibility study without excision. J Vasc Interv Radiol 2009; 20:1329-41; PMID:19800542; https://doi.org/10.1016/j.jvir.2009.06.029
  • Sabel MS, Kaufman CS, Whitworth P, Chang H, Stocks LH, Simmons R, Schultz M. Cryoablation of early-stage breast cancer: work-in-progress report of a multi-institutional trial. Ann Surg Oncol 2004; 11:542-9; PMID:15123465; https://doi.org/10.1245/ASO.2004.08.003
  • Inoue M, Nakatsuka S, Jinzaki M. Cryoablation of early-stage primary lung cancer. BioMed Res Int 2014; 2014:521691; PMID:24991559; https://doi.org/10.1155/2014/521691
  • Pua BB, Thornton RH, Solomon SB. Ablation of pulmonary malignancy: current status. J Vasc Interv Radiol 2010; 21:S223-32; PMID:20656232; https://doi.org/10.1016/j.jvir.2010.01.049
  • Kokoszka A, Scheinfeld N. Evidence-based review of the use of cryosurgery in treatment of basal cell carcinoma. Dermatol Surg 2003; 29:566-71; PMID:12786697; https://doi.org/10.1046/j.1524-4725.2003.29151b.x 10.1097/00042728-200306000-00002
  • Tanaka S. Immunological aspects of cryosurgery in general surgery. Cryobiology 1982; 19:247-62; PMID:7105777; https://doi.org/10.1016/0011-2240(82)90151-1
  • Uhlschmid G, Kolb E, Largiader F. Cryosurgery of pulmonary metastases. Cryobiology 1979; 16:171-8; PMID:477364; https://doi.org/10.1016/0011-2240(79)90028-2
  • Sabel MS, Nehs MA, Su G, Lowler KP, Ferrara JL, Chang AE. Immunologic response to cryoablation of breast cancer. Breast Cancer Res Treat 2005; 90:97-104; PMID:15770533; https://doi.org/10.1007/s10549-004-3289-1
  • Si T, Guo Z, Hao X. Immunologic response to primary cryoablation of high-risk prostate cancer. Cryobiology 2008; 57:66-71; PMID:18593573; https://doi.org/10.1016/j.cryobiol.2008.06.003
  • Thakur A, Littrup P, Paul EN, Adam B, Heilbrun LK, Lum LG. Induction of specific cellular and humoral responses against renal cell carcinoma after combination therapy with cryoablation and granulocyte-macrophage colony stimulating factor: a pilot study. J Immunother 2011; 34:457-67; PMID:21577139; https://doi.org/10.1097/CJI.0b013e31821dcba5
  • Scaviner D, Lefranc MP. The human T cell receptor alpha variable (TRAV) genes. Exp Clin Immunogenet 2000; 17:83-96; PMID:10810225; https://doi.org/10.1159/000019128 10.1159/000019129
  • Folch G, Lefranc MP. The human T cell receptor beta variable (TRBV) genes. Exp Clin Immunogenet 2000; 17:42-54; PMID:10686482; https://doi.org/10.1159/000019130 10.1159/000019123
  • Liu X, Venkataraman G, Lin J, Kiyotani K, Smith S, Montoya M, Nakamura Y, Kline J. Highly clonal regulatory T-cell population in follicular lymphoma—inverse correlation with the diversity of CD8 T cells. Oncoimmunology 2015; 4:e1002728; PMID:26155390; https://doi.org/10.1080/2162402X.2014.1002728
  • Jang M, Yew PY, Hasegawa K, Ikeda Y, Fujiwara K, Fleming GF, Nakamura Y, Park JH. Characterization of T cell repertoire of blood, tumor, and ascites in ovarian cancer patients using next generation sequencing. Oncoimmunology 2015; 4:e1030561; PMID:26451311; https://doi.org/10.1080/2162402X.2015.1030561
  • Park JH, Jang M, Tarhan YE, Katagiri T, Sasa M, Miyoshi Y, Kalari KR, Suman VJ, Weinshilboum R, Wang L et al. Clonal expansion of antitumor T cells in breast cancer correlates with response to neoadjuvant chemotherapy. Int J Oncol 2016; 49:471-8; PMID:27278091; https://doi.org/10.3892/ijo.2016.3540
  • Tamura K, Hazama S, Yamaguchi R, Imoto S, Takenouchi H, Inoue Y, Kanekiyo S, Shindo Y, Miyano S, Nakamura Y et al. Characterization of the T cell repertoire by deep T cell receptor sequencing in tissues and blood from patients with advanced colorectal cancer. Oncol Lett 2016; 11:3643-9; PMID:27284367; https://doi.org/10.3892/ol.2016.4465
  • Inoue H, Park JH, Kiyotani K, Zewde M, Miyashita A, Jinnin M, Kiniwa Y, Okuyama R, Tanaka R, Fujisawa Y et al. Intratumoral expression levels of PD-L1, GZMA, and HLA-A along with oligoclonal T cell expansion associate with response to nivolumab in metastatic melanoma. Oncoimmunology 2016; 5:e1204507; PMID:27757299; https://doi.org/10.1080/2162402X.2016.1204507
  • Chapman CG, Yamaguchi R, Tamura K, Weidner J, Imoto S, Kwon J, Fang H, Yew PY, Marino SR, Miyano S et al. Characterization of T-cell receptor repertoire in inflamed tissues of patients with Crohn's disease through deep sequencing. Inflamm Bowel Dis 2016; 22:1275-85; PMID:27135481; https://doi.org/10.1097/MIB.0000000000000752
  • Yew PY, Alachkar H, Yamaguchi R, Kiyotani K, Fang H, Yap KL, Liu HT, Wickrema A, Artz A, van Besien K et al. Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transpl 2015; 50:1227-34; PMID:26052909; https://doi.org/10.1038/bmt.2015.133
  • Gazzaniga S, Bravo A, Goldszmid SR, Maschi F, Martinelli J, Mordoh J, Wainstok R. Inflammatory changes after cryosurgery-induced necrosis in human melanoma xenografted in nude mice. J Invest Dermatol 2001; 116:664-71; PMID:11348453; https://doi.org/10.1046/j.0022-202x.2001.01313.x
  • Sabel MS, Arora A, Su G, Chang AE. Adoptive immunotherapy of breast cancer with lymph node cells primed by cryoablation of the primary tumor. Cryobiology 2006; 53:360-6; PMID:16973145; https://doi.org/10.1016/j.cryobiol.2006.07.004
  • Gage AA, Baust JM, Baust JG. Experimental cryosurgery investigations in vivo. Cryobiology 2009; 59:229-43; PMID:19833119; https://doi.org/10.1016/j.cryobiol.2009.10.001
  • Takeda H, Maruyama S, Okajima J, Aiba S, Komiya A. Development and estimation of a novel cryoprobe utilizing the Peltier effect for precise and safe cryosurgery. Cryobiology 2009; 59:275-84; PMID:19723517; https://doi.org/10.1016/j.cryobiol.2009.08.004
  • Hoffmann NE, Bischof JC. The cryobiology of cryosurgical injury. Urology 2002; 60:40-9; PMID:12206847; https://doi.org/10.1016/S0090-4295(02)01683-7
  • Erinjeri JP, Clark TW. Cryoablation: mechanism of action and devices. J Vasc Interv Radiol 2010; 21:S187-91; PMID:20656228; https://doi.org/10.1016/j.jvir.2009.12.403
  • Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P. Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer 2012; 12:860-75; PMID:23151605; https://doi.org/10.1038/nrc3380
  • Yatim N, Cullen S, Albert ML. Dying cells actively regulate adaptive immune responses. Nat Rev Immunol 2017; 17:262-75; PMID:28287107; https://doi.org/10.1038/nri.2017.9
  • Khong HT, Restifo NP. Natural selection of tumor variants in the generation of "tumor escape" phenotypes. Nat Immunol 2002; 3:999-1005; PMID:12407407; https://doi.org/10.1038/ni1102-999
  • Marincola FM, Jaffee EM, Hicklin DJ, Ferrone S. Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Adv Immunol 2000; 74:181-273; PMID:10605607; https://doi.org/10.1016/S0065-2776(08)60911-6
  • Anderson AC. Tim-3: an emerging target in the cancer immunotherapy landscape. Cancer Immunol Res 2014; 2:393-8; PMID:24795351; https://doi.org/10.1158/2326-6066.CIR-14-0039
  • Dardalhon V, Anderson AC, Karman J, Apetoh L, Chandwaskar R, Lee DH, Cornejo M, Nishi N, Yamauchi A, Quintana FJ et al. Tim-3/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells. J Immunol 2010; 185:1383-92; PMID:20574007; https://doi.org/10.4049/jimmunol.0903275
  • Jones RB, Ndhlovu LC, Barbour JD, Sheth PM, Jha AR, Long BR, Wong JC, Satkunarajah M, Schweneker M, Chapman JM et al. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J Exp Med 2008; 205:2763-79; PMID:19001139; https://doi.org/10.1084/jem.20081398
  • Qiu Y, Chen J, Liao H, Zhang Y, Wang H, Li S, Luo Y, Fang D, Li G, Zhou B et al. Tim-3-expressing CD4+ and CD8+ T cells in human tuberculosis (TB) exhibit polarized effector memory phenotypes and stronger anti-TB effector functions. PLoS Pathog 2012; 8:e1002984; PMID:23144609; https://doi.org/10.1371/journal.ppat.1002984
  • Jin HT, Anderson AC, Tan WG, West EE, Ha SJ, Araki K, Freeman GJ, Kuchroo VK, Ahmed R. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc Natl Acad Sci U S A 2010; 107:14733-8; PMID:20679213; https://doi.org/10.1073/pnas.1009731107
  • Cyktor JC, Carruthers B, Beamer GL, Turner J. Clonal expansions of CD8+ T cells with IL-10 secreting capacity occur during chronic Mycobacterium tuberculosis infection. PLoS One 2013; 8:e58612; PMID:23472214; https://doi.org/10.1371/journal.pone.0058612
  • Fang H, Yamaguchi R, Liu X, Daigo Y, Yew PY, Tanikawa C, Matsuda K, Imoto S, Miyano S, Nakamura Y. Quantitative T cell repertoire analysis by deep cDNA sequencing of T cell receptor alpha and beta chains using next-generation sequencing (NGS). Oncoimmunology 2014; 3:e968467; PMID:25964866; https://doi.org/10.4161/21624011.2014.968467
  • Choudhury NJ, Kiyotani K, Yap KL, Campanile A, Antic T, Yew PY, Steinberg G, Park J-H, Nakamura Y, O'Donnell PH. Low T-cell receptor diversity, high somatic mutation burden and high neoantigen load as predictors of clinical outcome in muscle-invasive bladder cancer. European Urology Focus 2016; 2:445-52; https://doi.org/10.1016/j.euf.2015.09.007
  • Giudicelli V, Chaume D, Lefranc MP. IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes. Nucleic Acids Res 2005; 33:D256-61; PMID:15608191; https://doi.org/10.1093/nar/gki010
  • Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods 2012; 9:357-9; PMID:22388286; https://doi.org/10.1038/nmeth.1923
  • Lefranc MP, Giudicelli V, Kaas Q, Duprat E, Jabado-Michaloud J, Scaviner D, Ginestoux C, Clement O, Chaume D, Lefranc G. IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res 2005; 33:D593-7; PMID:15608269; https://doi.org/10.1093/nar/gki065
  • Nelson WC, Pyo CW, Vogan D, Wang R, Pyon YS, Hennessey C, Smith A, Pereira S, Ishitani A, Geraghty DE. An integrated genotyping approach for HLA and other complex genetic systems. Hum Immunol 2015; 76:928-38; PMID:26027777; https://doi.org/10.1016/j.humimm.2015.05.001

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.